GTH Stock Recent News

Genetron Holdings has announced it will go private through an acquisition by a group of investors led by its co-founder and CEO Sizhen Wang and CICC Healthcare Investment Fund which values the Chinese precision oncology platform at US$126 million. The company's US-listed American Depository Shares (ADSs) jumped 27% in early Thursday trading to $1.1950.

Genetron Holdings Limited (NASDAQ:GTH ) Q1 2022 Earnings Conference Call June 2, 2022 8:30 AM ET Company Participants Evan Xu - Chief Financial Officer Sizhen Wang - Co-Founder, Chairman & Chief Executive Officer Conference Call Participants Yang Huang - Credit Suisse Operator Good morning, and thank you for standing by. Welcome to the First Quarter 2022 Genetron Health Earnings Conference Call.

BEIJING, May 23, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that it will report unaudited financial results for the first quarter ended March 31, 2022 on June 2, 2022 before the US market open.